Director Edward T. Mathers resigns from Mirum board and compensation committee

Mirum Pharmaceuticals, Inc.

Edward T. Mathers resigned as director and from the Compensation Committee effective September 1, 2022.
Resignation not due to any dispute or disagreement with the company on operations, policies, or practices.
No replacement for the board vacancy or committee seat was announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Edward T. Mathers

director

MIRM · Mirum Pharmaceuticals, Inc.

Effective: 2022-09-01
Filed: September 2, 2022, 7:59 PM ET

On September 1, 2022, Edward T. Mathers notified the board of directors (the “Board”) of Mirum Pharmaceuticals, Inc. (the “Company”) of his resignation as a director of the Company and as a member of the Compensation Committee of the Board, effective September 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Edward T. Mathers resigned as director at Mirum Pharmaceuticals, Inc..

Action: resigned
Role: director

Exact text from the filing

On September 1, 2022, Edward T. Mathers notified the board of directors (the “Board”) of Mirum Pharmaceuticals, Inc. (the “Company”) of his resignation as a director of the Company and as a member of the Compensation Committee of the Board, effective September 1, 2022.

View on SEC.gov

Mirum Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-237942

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.